Chestnut flour bread reduces glycemic response in a small trial in healthy adults

Changing the flour in bread can alter the glycemic response without reducing the meal’s carbohydrate content. In a randomized crossover trial in 14 healthy adults, bread made with half chestnut flour reduced a measure of the rise in glucose after a meal by 27%, compared with wheat bread. This finding covers three hours of monitoring, not diabetes prevention.

Chestnut flour bread and wheat bread shown side by side
NutritionEditorial illustration, not study data.

Two breads compared with equal carbohydrate content

Each participant consumed both study meals after an overnight fast. This crossover design allows researchers to compare the same person’s responses to the two breads, rather than responses from two separate groups.

The experimental bread combined 50% chestnut flour and 50% wheat flour. The control bread used only wheat flour. The meals had the same energy content and each provided 50 g of available carbohydrates. The researchers monitored capillary glucose and insulin for 180 minutes.

A lower overall response, especially toward the end of monitoring

The incremental area under the glucose curve was 27% lower after the chestnut bread. This measure summarizes the rise in glucose above its baseline value during monitoring. It does not mean that blood glucose was consistently 27% lower.

Glucose concentrations were 16% lower at 120 minutes and 14% lower at 150 minutes compared with the control bread. The abstract does not provide the absolute differences or their confidence intervals, which limits assessment of the clinical magnitude of the finding.

Total insulin exposure did not differ between the meals. However, the insulin peak occurred about 24 minutes earlier with the chestnut bread. This does not demonstrate improved insulin sensitivity.

A different composition, without a demonstrated mechanism

The researchers also characterized the polyphenols in the flours and breads. The chestnut-enriched bread contained more than the control bread. Fiber, resistant starch and polyphenols are possible explanations for a change in carbohydrate digestion.

But the trial compares two complete recipes. It cannot attribute the observed reduction to a specific compound or guarantee the same effect with any commercially available chestnut bread.

An acute finding, not yet a lasting benefit

The study supports the potential of this formulation to moderate the glycemic response to a meal in healthy adults. It does not show that regular consumption leads to lasting improvements in blood glucose, reduces cardiometabolic risk or produces the same result in people with diabetes.

Limitations to keep in mind

A small sample of 14 healthy adults, with monitoring limited to the response after a meal. Only the PubMed abstract was consulted, not the full text. Absolute effects, confidence intervals, funding and conflicts of interest have not been verified in the supplied dossier.

What we can take away

With equal carbohydrate content, this chestnut bread moderated the glycemic response over three hours. This is an interesting signal for a specific recipe, not evidence of diabetes prevention.

Sources and provenance

Partager cet article

X f in

An error or a source to report? Contact the editorial team.